抗风湿药物的致畸性——证据是什么?

Scandinavian journal of rheumatology. Supplement Pub Date : 1998-01-01

B Källén

{"title":"抗风湿药物的致畸性——证据是什么?","authors":"B Källén","doi":"","DOIUrl":null,"url":null,"abstract":"This review addresses on various methods used in the detection of human teratogenic effects of drug use in early pregnancy. Data are presented from the new Swedish ongoing recording of drug use in early pregnancy. These data do not indicate a teratogenic effect of the main antirheumatic drugs used in Sweden.","PeriodicalId":21501,"journal":{"name":"Scandinavian journal of rheumatology. Supplement","volume":"107 ","pages":"119-24"},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The teratogenicity of antirheumatic drugs--what is the evidence?\",\"authors\":\"B Källén\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This review addresses on various methods used in the detection of human teratogenic effects of drug use in early pregnancy. Data are presented from the new Swedish ongoing recording of drug use in early pregnancy. These data do not indicate a teratogenic effect of the main antirheumatic drugs used in Sweden.\",\"PeriodicalId\":21501,\"journal\":{\"name\":\"Scandinavian journal of rheumatology. Supplement\",\"volume\":\"107 \",\"pages\":\"119-24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scandinavian journal of rheumatology. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian journal of rheumatology. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

本文综述了用于检测妊娠早期药物使用对人类致畸作用的各种方法。数据来自瑞典正在进行的妊娠早期药物使用的新记录。这些数据并不表明瑞典使用的主要抗风湿药物有致畸作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The teratogenicity of antirheumatic drugs--what is the evidence?

This review addresses on various methods used in the detection of human teratogenic effects of drug use in early pregnancy. Data are presented from the new Swedish ongoing recording of drug use in early pregnancy. These data do not indicate a teratogenic effect of the main antirheumatic drugs used in Sweden.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Scandinavian journal of rheumatology. Supplement

自引率

0.00%

发文量